Newsbenzinga
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
· Published
Article summary
Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.
An excerpt from the original article.
Comments —
Loading comments…